Product code GXI— Neurology

Intracept Intraosseous Nerve Ablation System

Classification name
Probe, Radiofrequency Lesion
Device class
Class 2
Regulation
21 CFR 882.4725
Advisory panel
Neurology
Total cleared
66
First cleared
Most recent

Market context for product code GXI

FDA has cleared 66 devices under product code GXI between 1980 and 2026, filed by 32 applicant companies. No FDA device recalls reference this product code. Class II devices are moderate-risk and subject to general and special controls; most reach market through 510(k) clearance by demonstrating substantial equivalence to a predicate device.

Clearances per year

last 15 years

Top applicants under product code GXI

Adverse events under product code GXI

product code GXI
Death
3
Injury
171
Total
174

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Recent clearances under product code GXI

Data sourced from openFDA. This site is unofficial and independent of the FDA.